Rocephin (Ceftriaxone) IM Dosing Frequency
For intramuscular administration of Rocephin (ceftriaxone), the frequency is once daily (every 24 hours) for most indications in both adults and children.
Adult Dosing
The standard IM dosing for adults is 1-2 grams once daily, depending on infection severity 1. The total daily dose should not exceed 4 grams. For uncomplicated gonococcal infections specifically, a single 250 mg IM dose is recommended 1.
Pediatric Dosing
Neonates (≤28 days)
- 50-75 mg/kg once daily (every 24 hours) 2, 3
- Dosing varies by postnatal age and weight:
- ≤7 days: 50 mg/kg/day every 24 hours
7 days and ≤2000 g: 50 mg/kg/day every 24 hours
7 days and >2000 g: 50-75 mg/kg/day every 24 hours 2
Infants and Children (>28 days)
The frequency depends on the indication:
- Skin/soft tissue infections: 50-75 mg/kg once daily (or divided every 12 hours), max 2 g/day 1
- Acute otitis media: Single IM dose of 50 mg/kg (max 1 gram) 1
- Serious infections (non-meningitis): 50-75 mg/kg divided every 12 hours, max 2 g/day 1
- Meningitis: 100 mg/kg/day given once daily or divided every 12 hours, max 4 g/day 1
- UTI/bacteremia (22-60 days old): 50 mg/kg once daily (every 24 hours) 3
Key Clinical Considerations
The once-daily dosing advantage is supported by ceftriaxone's exceptionally long elimination half-life of 5.8-8.7 hours 4, which allows for sustained therapeutic concentrations with single daily administration. This pharmacokinetic profile makes it ideal for outpatient parenteral therapy 5, 6.
Important caveats:
- For meningitis in children, recent pharmacokinetic data suggests once-daily dosing (100 mg/kg) achieves superior CSF penetration compared to twice-daily dosing (50 mg/kg every 12 hours), with 88% vs 53% probability of target attainment at 24 hours 7
- Patients with augmented renal clearance (eGFR >60 mL/min/1.73 m²) may require twice-daily dosing (1 g every 12 hours) to maintain adequate drug levels 8
- In neonates receiving IV administration, infuse over 60 minutes to reduce bilirubin encephalopathy risk 1
The standard approach is once-daily IM administration for most infections, with twice-daily dosing reserved for serious pediatric infections (excluding meningitis) or patients with preserved/augmented renal function.